Ben Drucker
Chief Technical Officer
Ben has been in the Biologics CMC space for more than 20 years, holding a breadth of roles in regulatory, engineering, and manufacturing. Most recently he has contributed to the approval of several biosimilar products in immunology, oncology, and ophthalmology. He has held positions at Genentech and Coherus, and has also done independent consulting via his own firm(s). The Chemical Engineer in him is always scouting new paths for efficiency in drug development, analytics, and business improvement opportunities.